Login Register Cart 0
Generic placeholder image

Current Bioactive Compounds

Editor-in-Chief

ISSN (Print): 1573-4072
ISSN (Online): 1875-6646

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Structure-Activity Relationship and Antimicrobial Evaluation of N-Phenylpyrazole Curcumin Derivatives

Author(s): Heli Sanghvi and Satyendra Mishra*

Volume 16, Issue 4, 2020

Page: [481 - 488] Pages: 8

DOI: 10.2174/1573407215666190124115010

Price: $65

Abstract

Background: Curcumin, one of the most important pharmacologically significant natural products, has gained significant consideration among scientists for decades since its multipharmacological activities. 1, 3-Dicarbonyl moiety of curcumin was found to be accountable for the rapid degradation of curcumin molecule. The aim of present work is to replace 1, 3-dicarbonyl moiety of curcumin by pyrazole and phenylpyrazole derivatives with a view to improving its stability and to investigate the role of substitution in N-phenylpyrazole curcumin on its antibacterial activity against both Gram-positive as well as Gram-negative bacteria.

Methods: Pyrazole derivatives of curcumin were prepared by heating curcumin with phenyhydrazine/ substituted phenyhydrazine derivatives in AcOH. The residue was purified by silica gel column chromatography. Structures of purified compounds were confirmed by 1H NMR and Mass spectroscopy. The synthesized compounds were evaluated for their antibacterial activity by the microdilution broth susceptibility test method against gram positive (S. aureus) and gram negative (E. coli).

Results: Effects of substitution in N-phenylpyrazole curcumin derivatives against S. aureus and E. coli were studied. The most active N-(3-Nitrophenylpyrazole) curcumin (12) exhibits twenty-fold more potency against S. aureus (MIC: 10μg/mL)) and N-(2-Fluoroophenylpyrazole) curcumin (5) fivefold more potency against E. coli (MIC; 50 μg/mL) than N-phenylpyrazole curcumin (4). Whereas, a remarkable decline in anti-bacterial activity against S. aureus and E. coli was observed when electron donating groups were incorporated in N-phenylpyrazole curcumin (4). Comparative studies of synthesized compounds suggest the effects of electron withdrawing and electron donating groups on unsubstituted phenylpyrazole curcumin (4).

Conclusion: The structure-activity relationship (SAR) results indicated that the electron withdrawing and electron donating at N-phenylpyrazole curcumin played key roles for their bacterial inhibitory effects. The results of the antibacterial evaluation showed that the synthesized pyrazole derivatives of curcumin displayed moderate to very high activity in S. aureus. In conclusion, the series of novel curcumin derivatives were designed, synthesized and tested for their antibacterial activities against S. aureus and E. coli. Among them, N-(3-Nitrophenylpyrazole curcumin; 12) was most active against S. aureus (Gram-positive) and N-(2-Fluoroophenylpyrazole) curcumin (5) against E. coli (Gram-negative) bacteria.

Keywords: Curcumin, Pyrazole Derivatives of curcumin, Antibacterial Agent, Staphylococcus aureus, E. coli.

Graphical Abstract

[1]
Ammon, H. P.; Wahl, M. A. Pharmacology of Curcuma longa. Planta Med., 1991, 57, 1-7-8.
[2]
Eigner, D.; Scholz, D. Ferula asa-foetida and Curcuma longa in traditional medical treatment and diet in Nepal. J. Ethnopharmacol., 1999, 67(1), 1-6.
[http://dx.doi.org/10.1016/S0378-8741(98)00234-7] [PMID: 10616954]
[3]
Rezvani, M. Extract of Curcuma longa in the treatment of radiation lesions. Iranian J. Pharm. Res., 2004, 78-78.
[4]
Lodha, R.; Bagga, A. Traditional Indian systems of medicine. Ann. Acad. Med. Singapore, 2000, 29(1), 37-41.
[PMID: 10748962]
[5]
Masuda, T.; Maekawa, T.; Hidaka, K.; Bando, H.; Takeda, Y.; Yamaguchi, H. Chemical studies on antioxidant mechanism of curcumin: Analysis of oxidative coupling products from curcumin and linoleate. J. Agric. Food Chem., 2001, 49(5), 2539-2547.
[http://dx.doi.org/10.1021/jf001442x] [PMID: 11368633]
[6]
Lüer, S.; Troller, R.; Aebi, C. Antibacterial and antiinflammatory kinetics of curcumin as a potential antimucositis agent in cancer patients. Nutr. Cancer, 2012, 64(7), 975-981.
[http://dx.doi.org/10.1080/01635581.2012.713161] [PMID: 22973975]
[7]
Liu, C.H.; Huang, H.Y. Antimicrobial activity of curcumin-loaded myristic acid microemulsions against Staphylococcus epidermidis. Chem. Pharm. Bull. (Tokyo), 2012, 60(9), 1118-1124.
[http://dx.doi.org/10.1248/cpb.c12-00220] [PMID: 22976319]
[8]
Aggarwal, B.B.; Kumar, A.; Bharti, A.C. Anticancer potential of curcumin: Preclinical and clinical studies. Anticancer Res., 2003, 23(1A), 363-398.
[PMID: 12680238]
[9]
Chainani-Wu, N. Safety and anti-inflammatory activity of curcumin: A component of tumeric (Curcuma longa). J. Altern. Complement. Med., 2003, 9(1), 161-168.
[http://dx.doi.org/10.1089/107555303321223035] [PMID: 12676044]
[10]
Basnet, P.; Skalko-Basnet, N. Curcumin: an anti-inflammatory molecule from a curry spice on the path to cancer treatment. Molecules, 2011, 16(6), 4567-4598.
[http://dx.doi.org/10.3390/molecules16064567] [PMID: 21642934]
[11]
Jordan, W.C.; Drew, C.R. Curcumin-A natural herb with anti-HIV activity. J. Natl. Med. Assoc., 1996, 88(6), 333.
[PMID: 8691490]
[12]
Aggarwal, B.B.; Deb, L.; Prasad, S. Curcumin differs from tetrahydrocurcumin for molecular targets, signaling pathways and cellular responses. Molecules, 2014, 20(1), 185-205.
[http://dx.doi.org/10.3390/molecules20010185] [PMID: 25547723]
[13]
Wang, Y.J.; Pan, M.H.; Cheng, A.L.; Lin, L.I.; Ho, Y.S.; Hsieh, C.Y.; Lin, J.K. Stability of curcumin in buffer solutions and characterization of its degradation products. J. Pharm. Biomed. Anal., 1997, 15(12), 1867-1876.
[http://dx.doi.org/10.1016/S0731-7085(96)02024-9] [PMID: 9278892]
[14]
Ferrari, E.; Pignedoli, F.; Imbriano, C.; Marverti, G.; Basile, V.; Venturi, E.; Saladini, M. Newly synthesized curcumin derivatives: crosstalk between chemico-physical properties and biological activity. J. Med. Chem., 2011, 54(23), 8066-8077.
[http://dx.doi.org/10.1021/jm200872q] [PMID: 22029378]
[15]
Seo, H.J.; Wang, S.M.; Han, C.; Lee, S.J.; Patkar, A.A.; Masand, P.S.; Pae, C.U. Curcumin as a putative antidepressant. Expert Rev. Neurother., 2015, 15(3), 269-280.
[http://dx.doi.org/10.1586/14737175.2015.1008457] [PMID: 25644944]
[16]
Shailaja, M.; Damodara Gowda, K.M.; Vishakh, K.; Suchetha Kumari, N. Anti-aging role of curcumin by modulating the inflammatory markers in albino wistar rats. J. Natl. Med. Assoc., 2017, 109(1), 9-13.
[http://dx.doi.org/10.1016/j.jnma.2017.01.005] [PMID: 28259223]
[17]
Nabavi, S.F.; Thiagarajan, R.; Rastrelli, L.; Daglia, M.; Sobarzo-Sánchez, E.; Alinezhad, H.; Nabavi, S.M. Curcumin: A natural product for diabetes and its complications. Curr. Top. Med. Chem., 2015, 15(23), 2445-2455.
[http://dx.doi.org/10.2174/1568026615666150619142519] [PMID: 26088351]
[18]
Reddy, R.C.; Vatsala, P.G.; Keshamouni, V.G.; Padmanaban, G.; Rangarajan, P.N. Curcumin for malaria therapy. Biochem. Biophys. Res. Commun., 2005, 326(2), 472-474.
[http://dx.doi.org/10.1016/j.bbrc.2004.11.051] [PMID: 15582601]
[19]
Nandakumar, D.N.; Nagaraj, V.A.; Vathsala, P.G.; Rangarajan, P.; Padmanaban, G. Curcumin-artemisinin combination therapy for malaria. Antimicrob. Agents Chemother., 2006, 50(5), 1859-1860.
[http://dx.doi.org/10.1128/AAC.50.5.1859-1860.2006] [PMID: 16641461]
[20]
Teow, S.Y.; Liew, K.; Ali, S.A.; Khoo, A.S-B.; Peh, S.C. Antibacterial action of curcumin against Staphylococcus aureus: A brief review. J. Trop. Med., 2016, 2016 2853045
[http://dx.doi.org/10.1155/2016/2853045] [PMID: 27956904]
[21]
Braga, L.C.; Leite, A.A.; Xavier, K.G.; Takahashi, J.A.; Bemquerer, M.P.; Chartone-Souza, E.; Nascimento, A.M. Synergic interaction between pomegranate extract and antibiotics against Staphylococcus aureus. Can. J. Microbiol., 2005, 51(7), 541-547.
[http://dx.doi.org/10.1139/w05-022] [PMID: 16175202]
[22]
Schito, G.C. The importance of the development of antibiotic resistance in Staphylococcus aureus. Clin. Microbiol. Infect., 2006, 12(Suppl. 1), 3-8.
[http://dx.doi.org/10.1111/j.1469-0691.2006.01343.x] [PMID: 16445718]
[23]
Gibbons, S. Phytochemicals for bacterial resistance-Strengths, weaknesses and opportunities. Planta Med., 2008, 74(6), 594-602.
[http://dx.doi.org/10.1055/s-2008-1074518] [PMID: 18446673]
[24]
Wright, G.D. Resisting resistance: New chemical strategies for battling superbugs. Chem. Biol., 2000, 7(6), R127-R132.
[http://dx.doi.org/10.1016/S1074-5521(00)00126-5] [PMID: 10873842]
[25]
Wright, G.D. Bacterial resistance to antibiotics: enzymatic degradation and modification. Adv. Drug Deliv. Rev., 2005, 57(10), 1451-1470.
[http://dx.doi.org/10.1016/j.addr.2005.04.002] [PMID: 15950313]
[26]
Zhao, C.; Liu, Z.; Liang, G. Promising curcumin-based drug design: Mono-Carbonyl Analogues of Curcumin (MACs). Curr. Pharm. Des., 2013, 19(11), 2114-2135.
[PMID: 23116317]
[27]
Anand, P.; Sundaram, C.; Jhurani, S.; Kunnumakkara, A.B.; Aggarwal, B.B. Curcumin and cancer: an “old-age” disease with an “age-old” solution. Cancer Lett., 2008, 267(1), 133-164.
[http://dx.doi.org/10.1016/j.canlet.2008.03.025] [PMID: 18462866]
[28]
Chakraborti, S.; Dhar, G.; Dwivedi, V.; Das, A.; Poddar, A.; Chakraborti, G.; Basu, G.; Chakrabarti, P.; Surolia, A.; Bhattacharyya, B. Stable and potent analogues derived from the modification of the dicarbonyl moiety of curcumin. Biochemistry, 2013, 52(42), 7449-7460.
[http://dx.doi.org/10.1021/bi400734e] [PMID: 24063255]
[29]
Mishra, S.; Karmodiya, K.; Surolia, N.; Surolia, A. Synthesis and exploration of novel curcumin analogues as anti-malarial agents. Bioorg. Med. Chem., 2008, 16(6), 2894-2902.
[http://dx.doi.org/10.1016/j.bmc.2007.12.054] [PMID: 18194869]
[30]
Mishra, S.; Narain, U.; Mishra, R.; Misra, K. Design, development and synthesis of mixed bioconjugates of piperic acid-glycine, curcumin-glycine/alanine and curcumin-glycine-piperic acid and their antibacterial and antifungal properties. Bioorg. Med. Chem., 2005, 13(5), 1477-1486.
[http://dx.doi.org/10.1016/j.bmc.2004.12.057] [PMID: 15698763]
[31]
Mishra, S.; Tripathi, S.; Mishra, R.; Misra, K. Synthesis, Design, synthesis and characterisation of a novel anticancer prodrug having antiproliferative activity against prostrate tumour. Indian J. Chem., 2005, 44B, 2583-2588.
[32]
Srivastava, S.; Mishra, S.; Surolia, A.; Panda, D. C1, a highly potent novel curcumin derivative, binds to tubulin, disrupts microtubule network and induces apoptosis. Biosci. Rep., 2016, 36(2) e00323
[http://dx.doi.org/10.1042/BSR20160039] [PMID: 26980197]
[33]
Jha, N.S.; Mishra, A.; Mamidi, A.S.; Mishra, A.; Jha, S.K.; Surolia, A. Targeting human telomeric G-quadruplex DNA with curcumin and its synthesized analogues under molecular crowding conditions. RSC Advances, 2016, 6, 7474-7487.
[http://dx.doi.org/10.1039/C5RA17390F]
[34]
Jha, N.S.; Mishra, S.; Jha, S.K.; Surolia, A. Antioxidant activity and electrochemical elucidation of the enigmatic redox behavior of curcumin and its structurally modified analogues. Electrochim. Acta, 2015, 151, 574-583.
[http://dx.doi.org/10.1016/j.electacta.2014.11.026]
[35]
Mishra, S.; Kapoor, N.; Mubarak Ali, A.; Pardhasaradhi, B.V.V.; Kumari, A.L.; Khar, A.; Misra, K. Differential apoptotic and redox regulatory activities of curcumin and its derivatives. Free Radic. Biol. Med., 2005, 38(10), 1353-1360.
[http://dx.doi.org/10.1016/j.freeradbiomed.2005.01.022] [PMID: 15855053]
[36]
Ahsan, N.; Mishra, S.; Jain, M.K.; Surolia, A. Gupta, S. (3-Nitrophenylpyrazole) Curcumin inhibit aggregation, disrupt fibrils and modulate toxicity of Wild type and Mutant α-Synuclein. Sci. Rep., 2015, 5, 9862.
[http://dx.doi.org/10.1038/srep09862] [PMID: 25985292]
[37]
Mishra, S.; Patel, S.; Halpani, C.G. Recent updates in curcumin pyrazole and isoxazole derivatives: Synthesis and biological application. Chem. Biodivers., 2018.
[http://dx.doi.org/10.1002/cbdv.201800366] [PMID: 30460748]
[38]
Goel, A.; Kunnumakkara, A.B.; Aggarwal, B.B. Curcumin as “Curecumin”: from kitchen to clinic. Biochem. Pharmacol., 2008, 75(4), 787-809.
[http://dx.doi.org/10.1016/j.bcp.2007.08.016] [PMID: 17900536]
[39]
Hsu, C.H.; Cheng, A.L. Clinical studies with curcumin. Adv. Exp. Med. Biol., 2007, 595, 471-480.
[http://dx.doi.org/10.1007/978-0-387-46401-5_21] [PMID: 17569225]
[40]
Selvam, C.; Jachak, S.M.; Thilagavathi, R.; Chakraborti, A.K. Design, synthesis, biological evaluation and molecular docking of curcumin analogues as antioxidant, cyclooxygenase inhibitory and anti-inflammatory agents. Bioorg. Med. Chem. Lett., 2005, 15(7), 1793-1797.
[http://dx.doi.org/10.1016/j.bmcl.2005.02.039] [PMID: 15780608]
[41]
Narlawar, R.; Pickhardt, M.; Leuchtenberger, S.; Baumann, K.; Krause, S.; Dyrks, T.; Weggen, S.; Mandelkow, E.; Schmidt, B. Curcumin-derived pyrazoles and isoxazoles: Swiss army knives or blunt tools for Alzheimer’s disease? ChemMedChem, 2008, 3(1), 165-172.
[http://dx.doi.org/10.1002/cmdc.200700218] [PMID: 17943713]

Rights & Permissions Print Cite
Article Metrics
7
© 2024 Bentham Science Publishers | Privacy Policy